CLEMENS PETER A 4
4 · ACURA PHARMACEUTICALS, INC · Filed Feb 26, 2021
Insider Transaction Report
Form 4
CLEMENS PETER A
Senior VP and CFO
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$0.15/sh+40,000$6,040→ 431,197 total - Tax Payment
Common Stock
2021-02-24$0.40/sh−15,100$6,040→ 416,097 total - Exercise/Conversion
Stock options
2021-02-24−40,000→ 0 totalExercise: $0.15From: 2019-12-11Exp: 2023-12-11→ Common Stock (40,000 underlying)
Footnotes (5)
- [F1]Represents payment for exercise price.
- [F2]Exercise price is closing price of Issuer's common stock on December 11, 2018.
- [F3]Awarded under the Acura Pharmaceuticals Inc. 2016 Stock Option Plan
- [F4]100% of the shares underlying the options vest and are exercisable after one year on December 11, 2019
- [F5]Not Applicable.